Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Strommer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2015
Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth mediaP Matzneller, S Strommer, Z Österreicher, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2013
Effect of pulmonary surfactant on antimicrobial activity in vitroR Schwameis, Z Erdogan-Yildirim, M Manafi, et al.
The Journal of Investigative Dermatology|September 21, 2001
Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40T Kopp, J D Kieffer, A Rot, et al.
Clinical Pharmacology and Therapeutics|November 20, 2016
Colistin Reduces LPS-Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled TrialP Matzneller, S Strommer, C Drucker, et al.
Perspectives in Public Health|August 7, 2024
Creating meaningful knowledge exchange between young people and public health practitioners: what role can researchers play?M Barrett, S Shaw, S Jenner, et al.
International Journal of Antimicrobial Agents|May 17, 2017
Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage effluxU Matt, P Selchow, M Dal Molin, et al.
International Journal of Antimicrobial Agents|November 19, 2017
Corrigendum to 'Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux' [The International Journal of Antimicrobial Agents 50/1 (2017) 55-62]U Matt, P Selchow, M Dal Molin, et al.
British Journal of Cancer|May 14, 2009
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivoD Cejka, C Kuntner, M Preusser, et al.
BMC Public Health|June 6, 2023
Resilience in adolescence during the COVID-19 crisis in CanadaJ Chin, J Di Maio, T Weeraratne, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2015
Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth mediaP Matzneller, S Strommer, Z Österreicher, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2013
Effect of pulmonary surfactant on antimicrobial activity in vitroR Schwameis, Z Erdogan-Yildirim, M Manafi, et al.
The Journal of Investigative Dermatology|September 21, 2001
Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40T Kopp, J D Kieffer, A Rot, et al.
Clinical Pharmacology and Therapeutics|November 20, 2016
Colistin Reduces LPS-Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled TrialP Matzneller, S Strommer, C Drucker, et al.
Perspectives in Public Health|August 7, 2024
Creating meaningful knowledge exchange between young people and public health practitioners: what role can researchers play?M Barrett, S Shaw, S Jenner, et al.
International Journal of Antimicrobial Agents|May 17, 2017
Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage effluxU Matt, P Selchow, M Dal Molin, et al.
International Journal of Antimicrobial Agents|November 19, 2017
Corrigendum to 'Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux' [The International Journal of Antimicrobial Agents 50/1 (2017) 55-62]U Matt, P Selchow, M Dal Molin, et al.
British Journal of Cancer|May 14, 2009
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivoD Cejka, C Kuntner, M Preusser, et al.
BMC Public Health|June 6, 2023
Resilience in adolescence during the COVID-19 crisis in CanadaJ Chin, J Di Maio, T Weeraratne, et al.
Pageof 1